Inogen Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
15 Dezember 2021 - 12:00PM
Business Wire
Inogen, Inc. (NASDAQ: INGN), a medical technology company
offering innovative respiratory products for use in the homecare
setting, today announced that the Company’s management will be
participating in the 40th Annual J.P. Morgan Healthcare
Conference.
Inogen’s President and CEO, Nabil Shabshab, is scheduled to
present on Wednesday, January 12th, 2022 at 10:30 a.m. PT.
Interested parties can access the live audio webcast from the News
/ Events section of the Investor Relations page on the Inogen
website at www.inogen.com. A webcast replay will be available
approximately one hour after the conclusion of the live
presentation and will remain available for 90 days.
Inogen has used, and intends to continue to use, its Investor
Relations website, http://investor.inogen.com/, as a means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD. For more
information, visit http://investor.inogen.com/.
About Inogen
Inogen is a medical technology company offering innovative
respiratory products for use in the homecare setting. Inogen
primarily develops, manufactures and markets innovative portable
oxygen concentrators used to deliver supplemental long-term oxygen
therapy to patients suffering from chronic respiratory
conditions.
For more information, please visit www.inogen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211215005005/en/
Investor and Media Contacts Bryan Locke, Mike DeGraff,
Gabriella Coffey Inogen-SVC@sardverb.com (312) 895-4700
Inogen (NASDAQ:INGN)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Inogen (NASDAQ:INGN)
Historical Stock Chart
Von Mär 2023 bis Mär 2024